PFIZER INC (NYSE: PFE)

PFIZER INC

NYSE: PFE (Pfizer, Inc.)

Last update: 7 minutes ago

27.20

0.39 (1.45%)

Add to watchlist

Previous Close	26.81
Open	26.82
Volume	14,221,341
Avg. Volume (3M)	47,555,293
Market Cap	154,665,336,832

Price / Earnings (TTM)	20.00
Price / Earnings (Forward)	9.14
Price / Sales	2.47
Price / Book	1.78

52 Weeks Range	20.92 (-23%) — 27.94 (2%)
Earnings Date	28 Apr 2026
TTM Dividend Yield	6.20%

Market Trend

		Short Term	Medium Term
Industry	Drug Manufacturers - General (US)	Bullish	Mixed
	Drug Manufacturers - General (Global)	Bullish	Mixed
Stock	Pfizer, Inc.	Bearish	Bearish

AIStockmoo Score

-1.6

Analyst Consensus	-3.5
Insider Activity	-4.0
Price Volatility	-3.5
Technical Moving Averages	2.5
Technical Oscillators	0.5
Average	-1.60

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
PFE	155 B	6.20%	20.00	1.78
JNJ	588 B	2.11%	22.10	7.17
ABBV	407 B	0.71%	97.09	50.46
MRK	306 B	0.65%	17.01	5.65
BMY	124 B	4.84%	17.53	6.74
GSK	109 B	1.62%	14.69	5.29

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Sector	Healthcare
Industry	Drug Manufacturers - General
Investment Style	Large Value
% Held by Insiders	0.06%
% Held by Institutions	67.52%

Ownership

Name	Date	Shares Held
State Farm Mutual Automobile Insurance Co	31 Dec 2025	54,508,560

52 Weeks Range	20.92 (-23%) — 27.94 (2%)
Price Target Range	25.00 (-8%) — 35.00 (28%)
High	35.00 (Argus Research, 28.68%)	Buy
Median	27.00 (-0.74%)
Low	25.00 (RBC Capital, -8.09%)	Sell
	25.00 (Barclays, -8.09%)	Sell
	25.00 (UBS, -8.09%)	Hold
Average	27.43 (0.85%)
Total	1 Buy, 4 Hold, 2 Sell
Avg. Price @ Call	26.36

Firm	Date	Target Price	Call	Price @ Call
Argus Research	02 Mar 2026	35.00 (28.68%)	Buy	27.26
RBC Capital	25 Feb 2026	25.00 (-8.09%)	Sell	27.09
Barclays	20 Feb 2026	25.00 (-8.09%)	Sell	26.65
Cantor Fitzgerald	04 Feb 2026	27.00 (-0.73%)	Hold	26.78
Cantor Fitzgerald	27 Jan 2026	27.00 (-0.73%)	Hold	26.50
UBS	07 Jan 2026	25.00 (-8.09%)	Hold	25.28
Morgan Stanley	17 Dec 2025	27.00 (-0.73%)	Hold	25.04
Morgan Stanley	12 Dec 2025	28.00 (2.94%)	Hold	25.85
B of A Securities	15 Dec 2025	28.00 (2.94%)	Hold	26.43

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
BOSHOFF CHRISTOFFEL	27.09	27.09	6,550	177,440
BOURLA ALBERT	-	27.09	-475,544	-12,882,487
DAMICO JENNIFER B.	-	27.37	-17,703	-479,941
FONSECA LIDIA	-	27.09	-55,124	-1,493,309
LANKLER DOUGLAS M	-	27.09	-119,009	-3,223,954
MCDERMOTT MICHAEL	-	27.10	-40,226	-1,089,757
SAHNI PAYAL	-	27.09	-55,149	-1,493,986
Aggregate Net Quantity				-756,205
Aggregate Net Value ($)				-20,485,995
Aggregate Avg. Buy ($)				27.09
Aggregate Avg. Sell ($)				27.15
Insider Range ($)				27.09 (-0%) — 27.65 (1%)

Name	Holder	Date	Type	Quantity	Price	Value ($)
DAMICO JENNIFER B.	Officer	27 Feb 2026	Disposed (-)	655	27.65	18,111
MCDERMOTT MICHAEL	Officer	26 Feb 2026	Disposed (-)	3,503	27.10	94,931
BOSHOFF CHRISTOFFEL	Officer	25 Feb 2026	Acquired (+)	13,383	27.09	362,545
BOSHOFF CHRISTOFFEL	Officer	25 Feb 2026	Disposed (-)	6,833	27.09	185,106
BOURLA ALBERT	Officer	25 Feb 2026	Disposed (-)	475,544	27.09	12,882,487
BOURLA ALBERT	Officer	25 Feb 2026	Option execute	491,626	-	-
MCDERMOTT MICHAEL	Officer	25 Feb 2026	Disposed (-)	36,723	27.09	994,826
MCDERMOTT MICHAEL	Officer	25 Feb 2026	Option execute	37,925	-	-
FONSECA LIDIA	Officer	25 Feb 2026	Disposed (-)	55,124	27.09	1,493,309
FONSECA LIDIA	Officer	25 Feb 2026	Option execute	56,888	-	-
LANKLER DOUGLAS M	Officer	25 Feb 2026	Disposed (-)	119,009	27.09	3,223,954
LANKLER DOUGLAS M	Officer	25 Feb 2026	Option execute	122,907	-	-
DAMICO JENNIFER B.	Officer	25 Feb 2026	Disposed (-)	17,048	27.09	461,830
DAMICO JENNIFER B.	Officer	25 Feb 2026	Option execute	17,558	-	-
SAHNI PAYAL	Officer	25 Feb 2026	Disposed (-)	55,149	27.09	1,493,986
SAHNI PAYAL	Officer	25 Feb 2026	Option execute	56,888	-	-
Show more

Date	Type	Details
06 Feb 2026	Announcement	FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
05 Feb 2026	Announcement	Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
03 Feb 2026	Announcement	Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
03 Feb 2026	Announcement	Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
03 Feb 2026	CNBC	Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
03 Feb 2026	CNBC	Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
23 Jan 2026	CNBC	What obesity drugmakers see next in the market: More pills, easier access and drug combinations
20 Jan 2026	CNBC	Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry
10 Jan 2026	Announcement	Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer
10 Jan 2026	CNBC	2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
07 Jan 2026	Announcement	Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio
05 Jan 2026	Announcement	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
19 Dec 2025	CNBC	Nine of the largest pharma companies ink deals with Trump to lower drug prices
19 Dec 2025	CNBC	Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple
18 Dec 2025	Announcement	Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
17 Dec 2025	Announcement	PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
16 Dec 2025	CNBC	Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
16 Dec 2025	Announcement	Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
15 Dec 2025	Announcement	Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
12 Dec 2025	Announcement	Pfizer Declares First-Quarter 2026 Dividend
10 Dec 2025	Announcement	TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
Show more

TTM Dividend Yield	6.20%
5Y Average Dividend Yield	3.90%
Payout Ratio	122.46%

Ex Date	Announcement Date	Payment Date	Details
24 Jan 2025	12 Dec 2024	07 Mar 2025	0.43 Cash
08 Nov 2024	09 Oct 2024	02 Dec 2024	0.42 Cash
26 Jul 2024	26 Jun 2024	03 Sep 2024	0.42 Cash
09 May 2024	24 Apr 2024	14 Jun 2024	0.42 Cash
25 Jan 2024	14 Dec 2023	01 Mar 2024	0.42 Cash
09 Nov 2023	04 Oct 2023	04 Dec 2023	0.41 Cash
27 Jul 2023	22 Jun 2023	05 Sep 2023	0.41 Cash
11 May 2023	26 Apr 2023	09 Jun 2023	0.41 Cash
26 Jan 2023	09 Dec 2022	03 Mar 2023	0.41 Cash
03 Nov 2022	22 Sep 2022	05 Dec 2022	0.4 Cash
28 Jul 2022	23 Jun 2022	06 Sep 2022	0.4 Cash
12 May 2022	28 Apr 2022	10 Jun 2022	0.4 Cash
27 Jan 2022	10 Dec 2021	04 Mar 2022	0.4 Cash
04 Nov 2021	23 Sep 2021	06 Dec 2021	0.39 Cash
29 Jul 2021	24 Jun 2021	07 Sep 2021	0.39 Cash
06 May 2021	22 Apr 2021	04 Jun 2021	0.39 Cash
28 Jan 2021	11 Dec 2020	05 Mar 2021	0.39 Cash
05 Nov 2020	24 Sep 2020	01 Dec 2020	0.38 Cash
30 Jul 2020	25 Jun 2020	01 Sep 2020	0.38 Cash
07 May 2020	23 Apr 2020	05 Jun 2020	0.38 Cash
30 Jan 2020	16 Dec 2019	06 Mar 2020	0.38 Cash
07 Nov 2019	24 Sep 2019	02 Dec 2019	0.36 Cash
01 Aug 2019	28 Jun 2019	03 Sep 2019	0.36 Cash
09 May 2019	26 Apr 2019	07 Jun 2019	0.36 Cash
31 Jan 2019	15 Dec 2018	01 Mar 2019	0.36 Cash
08 Nov 2018	28 Sep 2018	03 Dec 2018	0.34 Cash
02 Aug 2018	29 Jun 2018	04 Sep 2018	0.34 Cash
10 May 2018	26 Apr 2018	01 Jun 2018	0.34 Cash
01 Feb 2018	18 Dec 2017	01 Mar 2018	0.34 Cash
09 Nov 2017	27 Sep 2017	01 Dec 2017	0.32 Cash
02 Aug 2017	22 Jun 2017	01 Sep 2017	0.32 Cash
10 May 2017	27 Apr 2017	01 Jun 2017	0.32 Cash
01 Feb 2017	12 Dec 2016	01 Mar 2017	0.32 Cash
08 Nov 2016	22 Sep 2016	01 Dec 2016	0.3 Cash
03 Aug 2016	23 Jun 2016	01 Sep 2016	0.3 Cash
11 May 2016	28 Apr 2016	01 Jun 2016	0.3 Cash
03 Feb 2016	14 Dec 2015	02 Mar 2016	0.3 Cash
04 Nov 2015	25 Sep 2015	01 Dec 2015	0.28 Cash
05 Aug 2015	25 Jun 2015	02 Sep 2015	0.28 Cash
06 May 2015	23 Apr 2015	02 Jun 2015	0.28 Cash
04 Feb 2015	14 Dec 2014	03 Mar 2015	0.28 Cash
05 Nov 2014	23 Oct 2014	02 Dec 2014	0.26 Cash
30 Jul 2014	26 Jun 2014	03 Sep 2014	0.26 Cash
07 May 2014	24 Apr 2014	03 Jun 2014	0.26 Cash
05 Feb 2014	16 Dec 2013	04 Mar 2014	0.26 Cash
06 Nov 2013	24 Oct 2013	03 Dec 2013	0.24 Cash
31 Jul 2013	27 Jun 2013	04 Sep 2013	0.24 Cash
08 May 2013	25 Apr 2013	04 Jun 2013	0.24 Cash
30 Jan 2013	17 Dec 2012	05 Mar 2013	0.24 Cash
07 Nov 2012	25 Oct 2012	04 Dec 2012	0.22 Cash
01 Aug 2012	28 Jun 2012	05 Sep 2012	0.22 Cash
09 May 2012	26 Apr 2012	05 Jun 2012	0.22 Cash
01 Feb 2012	12 Dec 2011	06 Mar 2012	0.22 Cash
08 Nov 2011	27 Oct 2011	06 Dec 2011	0.2 Cash
03 Aug 2011	23 Jun 2011	06 Sep 2011	0.2 Cash
11 May 2011	28 Apr 2011	07 Jun 2011	0.2 Cash
02 Feb 2011	13 Dec 2010	01 Mar 2011	0.2 Cash
04 Nov 2010	28 Oct 2010	01 Dec 2010	0.18 Cash
04 Aug 2010	24 Jun 2010	01 Sep 2010	0.18 Cash
05 May 2010	22 Apr 2010	01 Jun 2010	0.18 Cash
03 Feb 2010	14 Dec 2009	02 Mar 2010	0.18 Cash
04 Nov 2009	22 Oct 2009	01 Dec 2009	0.16 Cash
05 Aug 2009	25 Jun 2009	02 Sep 2009	0.16 Cash
06 May 2009	23 Apr 2009	02 Jun 2009	0.16 Cash
04 Feb 2009	15 Dec 2008	03 Mar 2009	0.32 Cash
05 Nov 2008	23 Oct 2008	02 Dec 2008	0.32 Cash
06 Aug 2008	26 Jun 2008	03 Sep 2008	0.32 Cash
07 May 2008	24 Apr 2008	03 Jun 2008	0.32 Cash
06 Feb 2008	17 Dec 2007	04 Mar 2008	0.32 Cash
07 Nov 2007	25 Oct 2007	04 Dec 2007	0.29 Cash
08 Aug 2007	28 Jun 2007	05 Sep 2007	0.29 Cash
09 May 2007	26 Apr 2007	05 Jun 2007	0.29 Cash
07 Feb 2007	18 Dec 2006	06 Mar 2007	0.29 Cash
08 Nov 2006	26 Oct 2006	05 Dec 2006	0.24 Cash
09 Aug 2006	22 Jun 2006	05 Sep 2006	0.24 Cash
10 May 2006	27 Apr 2006	06 Jun 2006	0.24 Cash
08 Feb 2006	12 Dec 2005	07 Mar 2006	0.24 Cash
08 Nov 2005	27 Oct 2005	06 Dec 2005	0.19 Cash
10 Aug 2005	23 Jun 2005	06 Sep 2005	0.19 Cash
11 May 2005	28 Apr 2005	07 Jun 2005	0.19 Cash
09 Feb 2005	13 Dec 2004	08 Mar 2005	0.19 Cash
09 Nov 2004	28 Oct 2004	03 Dec 2004	0.17 Cash
11 Aug 2004	24 Jun 2004	03 Sep 2004	0.17 Cash
12 May 2004	22 Apr 2004	04 Jun 2004	0.17 Cash
11 Feb 2004	15 Dec 2003	05 Mar 2004	0.17 Cash
12 Nov 2003	23 Oct 2003	04 Dec 2003	0.15 Cash
13 Aug 2003	26 Jun 2003	04 Sep 2003	0.15 Cash
14 May 2003	24 Apr 2003	05 Jun 2003	0.15 Cash
15 Jan 2003	16 Dec 2002	14 Feb 2003	0.15 Cash
13 Nov 2002	24 Oct 2002	05 Dec 2002	0.13 Cash
14 Aug 2002	27 Jun 2002	05 Sep 2002	0.13 Cash
15 May 2002	25 Apr 2002	06 Jun 2002	0.13 Cash
13 Feb 2002	18 Dec 2001	07 Mar 2002	0.13 Cash
14 Nov 2001	25 Oct 2001	06 Dec 2001	0.11 Cash
15 Aug 2001	28 Jun 2001	06 Sep 2001	0.11 Cash
16 May 2001	26 Apr 2001	07 Jun 2001	0.11 Cash
14 Feb 2001	18 Dec 2000	08 Mar 2001	0.11 Cash
15 Nov 2000	26 Oct 2000	07 Dec 2000	0.09 Cash
16 Aug 2000	22 Jun 2000	07 Sep 2000	0.09 Cash
16 Aug 2000	01 Jun 2000	15 Sep 2000	0.09 Cash
09 May 2000	27 Apr 2000	08 Jun 2000	0.09 Cash
16 Feb 2000	13 Dec 1999	09 Mar 2000	0.09 Cash
09 Nov 1999	28 Oct 1999	09 Dec 1999	0.08 Cash
04 Aug 1999	24 Jun 1999	09 Sep 1999	0.08 Cash
05 May 1999	22 Apr 1999	10 Jun 1999	0.22 Cash
10 Feb 1999	14 Dec 1998	11 Mar 1999	0.22 Cash
04 Nov 1998	22 Oct 1998	10 Dec 1998	0.19 Cash
05 Aug 1998	25 Jun 1998	10 Sep 1998	0.19 Cash
06 May 1998	23 Apr 1998	11 Jun 1998	0.19 Cash
04 Feb 1998	22 Jan 1998	12 Mar 1998	0.19 Cash
05 Nov 1997	23 Oct 1997	11 Dec 1997	0.17 Cash
30 Jul 1997	26 Jun 1997	11 Sep 1997	0.17 Cash
07 May 1997	24 Apr 1997	12 Jun 1997	0.34 Cash
05 Feb 1997	23 Jan 1997	13 Mar 1997	0.34 Cash
06 Nov 1996	24 Oct 1996	12 Dec 1996	0.3 Cash
31 Jul 1996	27 Jun 1996	12 Sep 1996	0.3 Cash
08 May 1996	25 Apr 1996	13 Jun 1996	0.3 Cash
07 Feb 1996	25 Jan 1996	14 Mar 1996	0.3 Cash
08 Nov 1995	26 Oct 1995	21 Dec 1995	0.26 Cash
02 Aug 1995	22 Jun 1995	21 Sep 1995	0.26 Cash
08 May 1995	27 Apr 1995	15 Jun 1995	0.52 Cash
06 Feb 1995	26 Jan 1995	16 Mar 1995	0.52 Cash
04 Nov 1994	27 Oct 1994	15 Dec 1994	0.47 Cash
01 Aug 1994	23 Jun 1994	15 Sep 1994	0.47 Cash
09 May 1994	28 Apr 1994	16 Jun 1994	0.47 Cash
07 Feb 1994	27 Jan 1994	17 Mar 1994	0.47 Cash
05 Nov 1993	28 Oct 1993	16 Dec 1993	0.42 Cash
02 Aug 1993	25 Jun 1993	16 Sep 1993	0.42 Cash
10 May 1993	22 Apr 1993	17 Jun 1993	0.42 Cash
08 Feb 1993	28 Jan 1993	18 Mar 1993	0.42 Cash
16 Nov 1992	22 Oct 1992	17 Dec 1992	0.37 Cash
03 Aug 1992	25 Jun 1992	17 Sep 1992	0.37 Cash
11 May 1992	23 Apr 1992	18 Jun 1992	0.37 Cash
03 Feb 1992	23 Jan 1992	19 Mar 1992	0.37 Cash
08 Nov 1991	24 Oct 1991	19 Dec 1991	0.33 Cash
01 Aug 1991	27 Jun 1991	19 Sep 1991	0.33 Cash
13 May 1991	25 Apr 1991	20 Jun 1991	0.33 Cash
22 Feb 1991	24 Jan 1991	21 Mar 1991	0.66 Cash
09 Nov 1990	25 Oct 1990	20 Dec 1990	0.6 Cash
06 Aug 1990	28 Jun 1990	20 Sep 1990	0.6 Cash
14 May 1990	26 Apr 1990	21 Jun 1990	0.6 Cash
05 Feb 1990	25 Jan 1990	22 Mar 1990	0.6 Cash
13 Nov 1989	26 Oct 1989	21 Dec 1989	0.55 Cash
24 Jul 1989	22 Jun 1989	21 Sep 1989	0.55 Cash
15 May 1989	27 Apr 1989	21 Jun 1989	0.55 Cash
23 Jan 1989	19 Dec 1988	22 Mar 1989	0.55 Cash
15 Nov 1988	27 Oct 1988	20 Dec 1988	0.5 Cash
25 Jul 1988	23 Jun 1988	20 Sep 1988	0.5 Cash
16 May 1988	28 Apr 1988	20 Jun 1988	0.5 Cash
12 Feb 1988	28 Jan 1988	21 Mar 1988	0.5 Cash
16 Nov 1987	22 Oct 1987	21 Dec 1987	0.45 Cash
27 Jul 1987	25 Jun 1987	21 Sep 1987	0.45 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2025	0.430	1	1.73
2024	1.68	4	6.33
2023	1.64	4	5.70
2022	1.60	4	3.12
2021	1.56	4	2.64
2020	1.52	4	4.13
2019	1.44	4	3.87
2018	1.36	4	3.28
2017	1.28	4	3.73
2016	1.20	4	3.89
2015	1.12	4	3.66
2014	1.04	4	3.52
2013	0.960	4	3.30
2012	0.880	4	3.70
2011	0.800	4	3.90
2010	0.720	4	4.33
2009	0.800	4	4.64
2008	1.28	4	7.62
2007	1.16	4	5.38
2006	0.960	4	3.91
2005	0.760	4	3.44
2004	0.680	4	2.67
2003	0.600	4	1.79
2002	0.520	4	1.79
2001	0.440	4	1.16
2000	0.450	5	1.03
1999	0.600	4	1.95
1998	0.760	4	1.92
1997	1.02	4	4.33
1996	1.20	4	9.14
1995	1.56	4	15.66
1994	1.88	4	30.78
1993	1.68	4	30.80
1992	1.48	4	25.82
1991	1.65	4	24.84
1990	2.40	4	75.18
1989	2.20	4	80.07
1988	2.00	4	87.23
1987	0.900	2	48.83
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	12.62%
Operating Margin (TTM)	35.17%
Diluted EPS (TTM)	1.38
Quarterly Revenue Growth (YOY)	-7.80%
Quarterly Earnings Growth (YOY)	-4.80%

Total Debt/Equity (MRQ)	68.84%
Current Ratio (MRQ)	1.26
Operating Cash Flow (TTM)	13.99 B
Levered Free Cash Flow (TTM)	15.05 B

Return on Assets (TTM)	4.79%
Return on Equity (TTM)	8.62%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)